CardGuardconfirms strong growth for LifeStar ACT device

Card Guard confirms strong growth trend for new LifeStar
ACT device in US market

Card Guard confirms strong growth trend for new LifeStar ACT
device in US market

- Since 14 April 2008 more billable patients than in full
year 2007
- LifeStar ACT in use by 50 top-ranking US hospitals and medical
centers

Neuhausen am Rheinfall / Switzerland - 16 April 2008 - Card
Guard AG (SWX Swiss Exchange: CARDG) today announced a new
record for its new Ambulatory Cardiac Telemetry device LifeStar
ACT. Until 14 April 2008 the system has been distributed to
6,134 patients. This number includes more patients than in the
full year 2007, when 6,132 patients were equipped and treated
with the monitoring system. In January 2008 the system was
distributed to 1,187 patients, in February 2008 it was
distributed to 1,612 patients, and in March 2008 it was
distributed to 2,327 patients. The treatment with LifeStar ACT
receives above-average reimbursement by most health and
insurance providers.

For full release please click on the link below:

here

=======================================================

DISCLAIMER - The content and accuracy of the information
contained in company news releases published on this service is
the responsibility of the originating company and not of
Reuters. [While Reuters makes every effort to verify with the
company concerned that any news release is genuine, it does not
perform any other checks to verify the content or accuracy of
the information in question].

Reuters: E-mail CEDPressReleases-Bangalore@reuters.com or
Pressrelease@reuters.com or call on Hotline +91 80 6677 1100 or
Derek Ryan on + 44 207 542 7992, e-mail derek.ryan@reuters.com